ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jian ZhangJian-Hua Chang

Abstract

To derive a more precise estimation of the relationship between the excision repair cross-complementing rodent repair deficiency, group 2 (ERCC2) Lys751Gln polymorphism and lung cancer risk, a meta-analysis was performed. A total of 23 studies including 8137 cases and 9824 controls were involved in this meta-analysis. Overall, significantly elevated lung cancer risk was associated with ERCC2 Gln allele when all studies were pooled into the meta-analysis (Lys/Gln versus Lys/Lys: odds ratio (OR)=1.10, 95% confidence interval (CI)=1.03-1.19; Gln/Gln versus Lys/Lys: OR=1.20, 95% CI=1.06-1.35; dominant model: OR=1.13, 95% CI=1.05-1.20; and recessive model: OR=1.15, 95% CI=1.03-1.29). In the subgroup analysis by ethnicity, significantly increased risk was only found for Caucasians (Gln/Gln versus Lys/Lys: OR=1.25, 95% CI=1.08-1.45; dominant model: OR=1.10, 95% CI=1.00-1.22; and recessive model: OR=1.22, 95% CI=1.06-1.40). When stratified by study design, statistically significantly elevated risks were found in hospital-based studies (Lys/Gln versus Lys/Lys: OR=1.12, 95% CI=1.03-1.22; Gln/Gln versus Lys/Lys: OR=1.24, 95% CI=1.06-1.44; dominant model: OR=1.15, 95% CI=1.06-1.24; and recessive model: OR=1.19, 95% CI=1.03-1.37) and popula...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Mar 5, 1999·Mutation Research·E BraithwaiteZ Wang
Feb 8, 2000·The Journal of Biological Chemistry·G S WinklerG Weeda
Feb 26, 2000·Carcinogenesis·J de Boer, J H Hoeijmakers
Nov 9, 2000·American Journal of Industrial Medicine·V RodríguezJ Zaplana
Mar 8, 2002·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Joel N HirschhornKurt Hirschhorn
Mar 14, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jae Yong ParkTae Hoon Jung
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Roberta PastorelliLuisa Airoldi
Jul 26, 2002·Molecular and Cellular Biology·Joyce T Reardon, Aziz Sancar
Oct 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Deyin XingDongxin Lin
Jan 9, 2003·The Lancet Oncology·Jerzy E TyczynskiD Maxwell Parkin
May 13, 2003·International Journal of Cancer. Journal International Du Cancer·Gang LiangDongxin Lin
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Mar 18, 2004·Journal of the National Cancer Institute·Sholom WacholderNathaniel Rothman
Jun 17, 2004·Environmental and Molecular Mutagenesis·Carsten HarmsWilliam W Au
Nov 18, 2004·Journal of the National Cancer Institute·Hans-Hermann Dubben
Nov 30, 2004·Statistics in Medicine·Ammarin ThakkinstianJohn Attia
Apr 20, 2005·Cancer Letters·Ulla VogelOle Raaschou-Nielsen
Apr 26, 2005·International Journal of Cancer. Journal International Du Cancer·Min ShenQing Lan
Jun 15, 2005·Cancer Causes & Control : CCC·Adonina TardonAaron Blair
Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Wen-Yi HuangRichard B Hayes
Jul 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Zhibin HuHongbing Shen
Oct 5, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ole Raaschou-NielsenUlla Vogel
Oct 24, 2007·Journal of Cancer Research and Clinical Oncology·Leelakumari SreejaRavindran Ankathil
Oct 25, 2007·International Journal of Cancer. Journal International Du Cancer·Geoffrey LiuDavid C Christiani
Aug 19, 2008·International Journal of Cancer. Journal International Du Cancer·Jeffrey S ChangJohn K Wiencke
Sep 10, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Mette SørensenOle Raaschou-Nielsen
Sep 16, 2008·Genetics·R V Rohlfs, B S Weir
Dec 17, 2009·Journal of Experimental & Clinical Cancer Research : CR·Zhihua YinBaosen Zhou
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Jan 10, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yun-Hua XuShun Lu

❮ Previous
Next ❯

Citations

May 11, 2012·Nature Reviews. Molecular Cell Biology·Emmanuel Compe, Jean-Marc Egly
Feb 22, 2014·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Xiang TanMingwu Chen
May 23, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hai-Ying Wu, Ling-Yu Ding
May 2, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lei HuiXiangsheng Li
Oct 29, 2010·Journal of Cancer Research and Clinical Oncology·Bo ChenXiao-Ting Wu
Dec 15, 2015·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Nikolai V LitviakovАndrei B Karpov
Sep 12, 2013·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Rim KhlifiAhmed Rebai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.